Capvizr
News · All summaries
Unclassified
T-Therapeutics
Series BUndisclosed
RoundSeries B
AmountUndisclosed
LeadProvides Development Update
HQCambridge, United States
DateNovember 5, 2026
THE DEAL, AT A GLANCE

T-Therapeutics

From the announcement
Who is involvedBacked by Provides Development Update, IMTX Stock NewsFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedT-Therapeutics raised Series B, announced 2026-11-05From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersT-Therapeutics' Series B is a capital-flow signal for TCR bispecific programmes, but the round-size signal is unresolved: the verified deal field records $0M, while the…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

T-Therapeutics · Financing Record

Explore source-linked visual explanations for T-Therapeutics. Unsupported claims are withheld while source review continues.

Record 15391 · Recorded date: 2026-11-05

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime